(Q25257632)

6 July 2017

title

Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations (English)

1 reference

6 July 2017

1 reference

3

0 references

Helle Krogh Johansen

series ordinal

2

0 references

Karsten Juhl Jørgensen

series ordinal

1

object named as

Karsten J Jørgensen

0 references

language of work or name

English

0 references

publication date

19 January 2006

1 reference

6 July 2017

1 reference

6 July 2017

volume

7

1 reference

6 July 2017

issue

1

0 references

page(s)

3

1 reference

Unjustified restrictions on letters to the editor

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Medical journals are an extension of the marketing arm of pharmaceutical companies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Voriconazole versus amphotericin B in cancer patients with neutropenia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Of mites and men: reference bias in narrative review articles: a systematic review

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Quotation bias in reviews of the diet-heart idea

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Reference bias in reports of drug trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome

7 April 2017

1 reference

https://api.crossref.org/works/10.1186/1745-6215-7-3

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Interface between authorship, industry and science in the domain of therapeutics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Must we really fear toxicity of conventional amphotericin B in oncological patients?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Routine versus selective antifungal administration for control of fungal infections in patients with cancer.

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-7-3

Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-7-3

Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-7-3

Invasive aspergillosis: current and future challenges in diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-7-3

Financial Associations of Authors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-7-3

[Are relative risks and odds ratios in abstracts believable? Secondary publication].

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1399447

Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16542031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1745-6215-7-3

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference

6 July 2017

1 reference